Literature DB >> 16492455

Alzheimer's disease: issues and challenges in primary care.

Valerie T Cotter1.   

Abstract

The challenge in primary care practice is identifying persons with symptoms of Alzheimer's Disease (AD) who often have limited capacity to recognize their own symptoms and attribute cognitive decline to chronic illness or aging. Brief office visit communications without an informant,such as a spouse or adult child rarely uncover mild stage AD. Clinicians in primary care fail to screen older adults for AD on a routine basis be-cause of insufficient time, inadequate reimbursement for services, and uncertainty about the value of an early diagnosis. Although current pharmacologic and behavioral interventions and patient education do not prevent eventual disease progression, they arguably lead to improvements in understanding, self-efficacy, and quality of life for the patient and family.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16492455     DOI: 10.1016/j.cnur.2005.09.005

Source DB:  PubMed          Journal:  Nurs Clin North Am        ISSN: 0029-6465            Impact factor:   1.208


  4 in total

1.  Dementia in life writing: our health care system in the words of the sufferer.

Authors:  Martina Zimmermann
Journal:  Neurol Sci       Date:  2010-12-21       Impact factor: 3.307

2.  Validation of a serum screen for Alzheimer's disease across assay platforms, species, and tissues.

Authors:  Sid E O'Bryant; Guanghua Xiao; Fan Zhang; Melissa Edwards; Dwight C German; Xiangling Yin; Tori Como; Joan Reisch; Ryan M Huebinger; Neill Graff-Radford; Dennis Dickson; Robert Barber; James Hall; Padraig O'Suilleabhain; Paula Grammas
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

3.  Accessing community-based and long-term care services: challenges facing persons with frontotemporal dementia and their families.

Authors:  Darby Morhardt
Journal:  J Mol Neurosci       Date:  2011-08-09       Impact factor: 3.444

4.  A depressive endophenotype of mild cognitive impairment and Alzheimer's disease.

Authors:  Leigh A Johnson; James R Hall; Sid E O'Bryant
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.